Vitamin D
It’s important. Once activated, vitamin D acts like a hormone: it directly switches genes on and off. Around 3% of the human genome has binding sites for the vitamin D receptor, meaning hundreds of genes across immune, metabolic, and brain function are regulated by it.
Vitamin D is a nutrient the body needs, along with calcium, to build bones and keep them healthy. The body can absorb calcium only if it has enough vitamin D. Calcium is a major part of bones. Vitamin D also has many other uses in the body. It supports immune health and helps keep muscles and brain cells working. For the role of muscle as a longevity organ and training recommendations, see the muscle module.
Key takeaways
- D3 at 2,000–4,000 IU/day maintenance — target serum 25(OH)D of 40–60 ng/mL; check bloodwork every 6–12 months
- K2 (MK-7) 90–180 mcg/day is mandatory with D3 — without K2, vitamin D-driven calcium deposits in arteries instead of bone; must be trans-MK-7 (natural, bioactive)
- Magnesium 300–400mg/day is a required cofactor — both D3 conversion steps require magnesium; ~48% of the US population is magnesium-insufficient
- Sun exposure UV-B produces 10,000–20,000 IU — peaks in first 10–20 min at solar noon; above ~50°N latitude, October–March = too little UV-B to make vitamin D, supplement mandatory
- ~3% of your genome has vitamin D receptors — hundreds of immune, metabolic, and brain genes are directly regulated by vitamin D
Sun exposure — how to get vitamin D without burning
Sun is the best source — a single midday session can produce 10,000–20,000 IU in skin, self-regulated (body stops at saturation).
- UV-B (280–315 nm) required — only present when sun is high enough: shadow shorter than your height. Sunrise/sunset = zero vitamin D regardless of brightness
- Best window: solar noon ±2 hours (roughly 10am–2pm). Need UV Index ≥3
- More skin = more D3 — torso + back in direct sun is far more effective than face + hands
- Stop before redness — D3 production peaks in the first 10–20 min; burning adds no more D3, only damage
- Sunscreen blocks UV-B — apply after your vitamin D window
- Glass blocks UV-B — sunny window = no vitamin D
- Above ~50°N (UK, northern Europe, Canada): October–March = too little UV-B to make vitamin D, regardless of weather. A 1988 study found winter sun made no previtamin D3 in Edmonton (52°N) from October to March, and in Boston (42°N) from November to February — supplement mandatory
| UV Index | Condition | Exposure time (fair skin, arms+legs) |
|---|---|---|
| 1–2 | Winter / high latitude / overcast | Zero — supplement instead |
| 3–5 | Spring/autumn, moderate latitude | 20–40 min |
| 6–8 | Summer midday, sunny | 10–20 min |
| 9–11+ | Tropical / high altitude | 5–10 min |
How to take supplemental vitamin D
- Take with food containing monounsaturated fat (e.g. extra virgin olive oil) — can increase absorption up to 32% (dietary fat triggers bile release which improves D3 uptake)
- Take earlier in the day — late-night D3 may interfere with sleep in some people
- Do not overdose — 2000–4000 IU/day is the well-studied maintenance range for adults. Meta-analysis (PMID 36853379) shows 3200–4000 IU/day raises hypercalcemia risk slightly; do not exceed without bloodwork
- Check blood 25(OH)D and Ca every 6–12 months to confirm you are in range and not over-supplementing. Target: 40–60 ng/mL (100–150 nmol/L)
- Do NOT take supplemental Calcium unless a diagnosed deficiency — dietary calcium from real food is sufficient if vitamin D and K2 are adequate; excess supplemental Ca without K2 increases arterial calcification risk
Vitamin K2 (MK-7) — dose and role
MK-7 (menaquinone-7) is the long-chain form of K2 with the longest half-life (~72h vs ~1–2h for MK-4), highest tissue penetration, and highest potency for carboxylating K-dependent proteins.
Why it matters with vitamin D: Vitamin D dramatically increases intestinal calcium absorption. Without sufficient K2, that extra circulating calcium may deposit in soft tissue and arteries instead of bone — the opposite of what you want. K2 activates two key proteins:
- Osteocalcin (bone Gla protein) — pulls calcium into bone matrix
- Matrix Gla protein (MGP) — inhibits calcium deposits in arterial walls
Dose:
- 90–180 mcg/day — a 3-year landmark RCT used 180 mcg/day and significantly reduced bone mineral density loss; 90 mcg is the minimum effective dose for osteocalcin carboxylation in most adults
- Take with vitamin D and fat for co-absorption (both are fat-soluble)
- Must be trans-MK-7 (natural, bioactive isomer) — some cheaper products contain cis-MK-7 which is largely inactive
- ⚠️ Warfarin / anticoagulant users: K2 directly antagonizes warfarin-class drugs — do not supplement without physician supervision
Magnesium — dose and role in vitamin D activation
When supplementing vitamin D, magnesium is a required cofactor for both enzymatic conversion steps that make vitamin D biologically active:
- Liver: 25-hydroxylase (CYP2R1) converts D3 → 25(OH)D (the main circulating storage form)
- Kidney: 1α-hydroxylase (CYP27B1) converts 25(OH)D → 1,25(OH)2D (the active hormone)
Without adequate magnesium, both steps are impaired — you can supplement vitamin D and still not raise serum 25OHD meaningfully. A 2022 RCT confirmed this directly: the combined magnesium + vitamin D group achieved the greatest increase in serum 25OHD vs vitamin D alone. Separately, ~48% of the US population has chronically suboptimal magnesium intake.
Dose:
- 300–400 mg elemental magnesium/day covers vitamin D metabolism support and general physiological need
- Best absorbed forms: bisglycinate (glycinate chelate), malate, citrate — in that order of preference
- Avoid magnesium oxide — ~4% bioavailability; it is mainly a laxative
- If already using klatiLYTE: ~280mg elemental Mg per moderate-activity dose is included — likely covered
- Split over 2 doses if >200mg per sitting to avoid GI effects
- check klatiAPPROVED for klati approved sources
Research
14 studies · 2 meta-analyses and reviews · 6 RCTs · top grade B
- [B, review] A ChIP-seq defined genome-wide map of vitamin D receptor binding — Ramagopalan et al. (2010 · PMID: 20736230 · DOI: 10.1101/gr.107920.110) — ~3% of the human genome has VDR binding sites; vitamin D directly regulates hundreds of immune, metabolic, and brain genes ⚠️ older evidence (older evidence)
- [B, review] Vitamin D toxicity — a clinical perspective — Marcinowska-Suchowierska et al. (2018 · PMID: 30294301 · DOI: 10.3389/fendo.2018.00550) — safety thresholds; toxicity typically from excessive supplementation, not sun ⚠️ Limitation not yet assessed
- [B, rct] Dietary fat increases vitamin D-3 absorption — Dawson-Hughes et al. (2015 · PMID: 25441954 · DOI: 10.1016/j.jand.2014.09.014) — fat consumed with vitamin D significantly increases 25(OH)D plasma levels ⚠️ older evidence (older evidence)
- [B, review] Type of dietary fat associated with 25-hydroxyvitamin D3 increment in response to supplementation (2011 · PMCID: PMC3200243 · DOI: 10.1210/jc.2011-1518) — monounsaturated fat optimal for VD absorption ⚠️ older evidence (older evidence)
- [B, rct] The effect of combined magnesium and vitamin D supplementation on vitamin D status — Cheung et al. (2022 · PMID: 35576873 · DOI: 10.1016/j.nut.2022.111674) — magnesium is required for VD activation; combined supplementation more effective than VD alone ⚠️ Limitation not yet assessed
- [B, review] Suboptimal magnesium status in the United States: are the health consequences underestimated? — Rosanoff et al. (2012 · PMID: 22364157 · DOI: 10.1111/j.1753-4887.2011.00465.x) — majority of the population is magnesium-insufficient; impairs VD activation and dozens of enzymatic processes ⚠️ older evidence (older evidence)
- [B, rct] 3-year MK-7 (vitamin K2) supplementation improves bone density in postmenopausal women — Knapen et al. (2013 · PMID: 23525894 · DOI: 10.1007/s00198-013-2325-6) — K2 (MK-7) improves bone density and reduces arterial stiffness over 3 years ⚠️ older evidence (older evidence)
- [B, meta-analysis] Efficacy of vitamin K2 in prevention and treatment of postmenopausal osteoporosis (2022 · PMID: 36033779 · DOI: 10.3389/fpubh.2022.979649) ⚠️ Limitation not yet assessed
- [B, rct] Vitamin K2 and D supplementation in patients with aortic valve calcification (2022 · PMID: 35465686 · DOI: 10.1161/CIRCULATIONAHA.121.057008) ⚠️ Limitation not yet assessed
- [B, review] Effects of vitamin K2 and D supplementation on coronary artery disease in men (2024 · PMID: 38938724 · DOI: 10.1016/j.jacadv.2023.100643) ⚠️ Limitation not yet assessed
- [B, rct] Annual high-dose oral vitamin D increases fall risk in older women — Sanders et al. (2010 · PMID: 20460620 · DOI: 10.1001/jama.2010.594) · ⚖️ mixed — warning: single annual megadose increased fall risk; supports daily low-dose protocol ⚠️ older evidence (older evidence)
- [B, rct] Urinary tract stone risk in the Women’s Health Initiative calcium + vitamin D trial (2011 · PMID: 21525191 · DOI: 10.3945/ajcn.110.003350) · ⚖️ mixed — elevated kidney stone risk without K2 co-supplementation for proper calcium routing ⚠️ older evidence (older evidence)
- [B, meta-analysis] Long-term supplementation with 3200–4000 IU vitamin D daily is safe and effective (2023 · PMID: 36853379 · DOI: 10.1007/s00394-023-03124-w) ⚠️ Limitation not yet assessed
- [B, cohort] Webb et al. 1988 — Influence of season and latitude on cutaneous vitamin D3 synthesis (JCEM, Boston + Edmonton winter sunlight study) (1988 · PMID: 2839537 · DOI: 10.1210/jcem-67-2-373) — winter sunlight made no previtamin D3 in Boston (42°N) November–February or Edmonton (52°N) October–March; independent (US government) ⚠️ Experimental photoproduction model — measured previtamin D3 formation in test solutions exposed to ambient sunlight across latitudes. Not human in vivo endpoint. Older evidence (1988) but canonical reference in photobiology. (older evidence)
See all research and methodology for the complete reference list and grading criteria. Unfamiliar with a term? Check the glossary.